CEPR researches how US government-granted monopolies of patents, copyrights, and other forms of intellectual property redistribute income upward and the role of digital global trade and international commercial agreements on inequality and economic mobility.
CEPR investiga cómo los monopolios de patentes, derechos de autor y otras formas de propiedad intelectual otorgados por el gobierno de los Estados Unidos redistribuyen el ingreso hacia arriba. CEPR analiza el papel del comercio mundial digital y los acuerdos comerciales internacionales sobre desigualdad y movilidad económica.
CEPR researches how US government-granted monopolies of patents, copyrights, and other forms of intellectual property redistribute income upward and the role of digital global trade and international commercial agreements on inequality and economic mobility.
CEPR investiga cómo los monopolios de patentes, derechos de autor y otras formas de propiedad intelectual otorgados por el gobierno de los Estados Unidos redistribuyen el ingreso hacia arriba. CEPR analiza el papel del comercio mundial digital y los acuerdos comerciales internacionales sobre desigualdad y movilidad económica.
· Op-Ed/Commentary
Economic Crisis and RecoveryIntellectual Property The National Debt and Patent/Copyright MonopoliesDean Baker / October 18, 2021
· Op-Ed/Commentary
COVID-19Intellectual Property The Preventable Horrors of the Pandemic and the Short Case for Open ResearchDean Baker / October 11, 2021
· Op-Ed/Commentary
Intellectual Property High Drug Prices and the Refusal to Talk Seriously About Debt and DeficitsDean Baker / October 03, 2021
· Op-Ed/Commentary
Intellectual Property Big Pharma Fights BackDean Baker / September 29, 2021
· Op-Ed/Commentary
Intellectual Property Sickening Indeed: A Review of Sickening, by John AbramsonDean Baker / September 26, 2021
· Op-Ed/Commentary
Globalization and TradeInequalityIntellectual Property The US and China: A Productive Path ForwardDean Baker / September 24, 2021
· Op-Ed/Commentary
COVID-19Intellectual PropertyTechnology Biden Can Transfer mRNA Technology and Leave the Legal Burdens with Moderna and PfizerDean Baker / September 22, 2021
· Op-Ed/Commentary
Intellectual Property Evil Doers: The Pharmaceutical Industry and the PandemicDean Baker / September 20, 2021
· Op-Ed/Commentary
Economic Crisis and RecoveryIntellectual Property Saving $3.5 Trillion on Prescription Drugs to Pay for Bernie Sanders’s Big AgendaDean Baker / September 13, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryIntellectual Property If a Vaccine Resistant Strain Develops in Africa, Will Dr. Fauci Lose His Job?Dean Baker / August 04, 2021
